Form 4: Elanco Animal Health Executive Sells Shares in Recent Transaction

Sentiment:

SEC Form 4 Filing


James M. Meer, Chief Accounting Officer of Elanco Animal Health, disposed of 414 shares of common stock on January 3, 2025.

Summary

  • James M. Meer, the Chief Accounting Officer of Elanco Animal Health, sold 414 shares of the company's common stock.
  • The transaction occurred on January 3, 2025.
  • The shares were sold at a price of $11.98 per share.
  • Following the transaction, Mr. Meer directly owns 48,773 shares of Elanco Animal Health stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of an insider transaction, with no indication of positive or negative sentiment.

Industry Context

This is a routine disclosure of an insider transaction, which is common for publicly traded companies. It does not indicate any specific trend in the animal health industry.

Comparison to Industry Standards

  • Insider transactions are a normal part of the operations of publicly listed companies.
  • Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders.
  • The sale of 414 shares is a relatively small transaction compared to the total number of shares outstanding for Elanco Animal Health.

Stakeholder Impact

  • The transaction is unlikely to have a significant impact on stakeholders, as it is a small sale by an executive.

Key Dates

DateDescription
01/03/2025Date of the stock sale transaction.
01/07/2025Date the Form 4 was signed.

Keywords

Elanco Animal Health, insider trading, stock sale, James M. Meer, executive transaction, share disposal, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.